The fast track 
to digital

Accelerate clinical study start up by 50% with fast, trailblazing clinical trial technology.

Introducing Medable:

Our powerful, user-friendly platform is designed for participants, sites, and sponsors all in one integrated solution.

Single platform technology solution

Digital Experiences

Total Consent, TeleVisit

Intelligent Automation

Higher data quality faster

Digital Measures

Biomarkers and endpoints

Evidence Platform

Outcomes and endpoints with eCOAs, sensors

Digital Data Flow

Data structure, format (USDM) and integrations

Deep evidence generation

Access is driven through the digital experience layer with consent and TeleVisit. Intelligent automation weaved throughout all elements of the platform and then we really focus on data or evidence with an expanding list of digital measures to support outcomes and endpoints through a single system with an optimised and standardised data flow.

Explore more of our featured content

Blog posts

No delays: How Medable achieves a 99% device shipment rate

With BBC Research forecasting that “the global smartphone-based patient monitoring market should reach $21.5 billion by 2027,” it’s safe to say that smartphones, tablets, and other devices have become a cornerstone of modern clinical trials.

Today’s trials use smart devices to help facilitate several important trial activities, like informed consent, data collection, patient feedback, and more. As a result, ensuring device delivery logistics has become a crucial step in getting a trial started and keeping participants engaged throughout its duration.

At Medable, we often handle device shipping for our customers' clinical trials. The team responsible for providing this service, led by Carl Franzetti, SVP of Professional Global Services has a market-leading 99% device shipment rate, with the remaining 1% resulting from normal business operation limitations such as weather outages.

The result? Our customer’s trials start on time and their participants are better engaged. 

Blog posts

Rapid evolution: How DCT’s DNA became standard in modern clinical trials

It’s impossible to deny how different clinical trials look almost four years after the pandemic revolutionized clinical research. Today, the digital and decentralized tools and technologies that enabled clinical trials to carry on through the COVID-19 pandemic are present (in some form) in nearly all clinical trials, a far cry from the dynamics of 2019.

White Papers, Case Studies, Reports

Record-breaking enrollment achieved in weight-loss study

A top 10 pharmaceutical company approached Medable seeking support for their Phase III diabetes study. Their primary goal was to reduce the participant enrollment phase timeline to get the study underway as quickly as possible.

Discover how Studio with Medable AI gives you control and efficiency in 
study launch.